ROCKWELL MEDICAL, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Rockwell Medical, Inc.

Lead Plaintiff Deadline is September 25, 2018

NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces the filing of a class action lawsuit on behalf of purchasers of the securities of Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell”) between March 16, 2018 and June 26, 2018, inclusive (the “Class Period”), in the United States District Court for the Eastern District of New York.

Investors who have incurred losses in the shares of Rockwell Medical, Inc. are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, www.whafh.com.

If you have incurred losses in the shares of Rockwell Medical, Inc., you may, no later than September 25, 2018, request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in Rockwell Medical, Inc.

According to the filed complaint, defendants during the Class Period made materially false and/or misleading statements and/or failed to disclose that: 

• Rockwell was aware that the Centers for Medicare and Medicaid Services would not pursue Rockwell’s proposal for separate reimbursement for Triferic;
   
• the estimated reserves in Rockwell’s Form 10-Q for the quarter ended March 31, 2018 were misstated;
   
• there was a material weakness in Rockwell’s internal controls over financial reporting;
   
• consequently, Rockwell’s internal controls over financial reporting were ineffective during the Class Period;
   
• defendant Robert L. Chioini, Rockwell’s former Chief Executive Officer, withheld material information regarding Triferic from Rockwell’s auditor, corporate counsel and five independent directors of Rockwell’s Board; and
   
• as a result, defendants’ statements about Rockwell’s business, operations and prospects were materially false and misleading and/or lacked reasonable bases at all relevant times.

Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com.

## Follow the firm and learn about newly filed cases on Twitter and Facebook. ##

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: gstone@whafh.com, kcooper@whafh.com or classmember@whafh.com
Tel: (800) 575-0735 or (212) 545-4774

Attorney Advertising. Prior results do not guarantee or predict a similar outcome.